• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection

tetano

Editor, Senior Moderator
Exp Mol Pathol. 2015 Jul 3. pii: S0014-4800(15)00141-0. doi: 10.1016/j.yexmp.2015.07.001. [Epub ahead of print]
[h=1]Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection.[/h] Mor?n J[SUP]1[/SUP], Ram?rez G[SUP]2[/SUP], Jim?nez L[SUP]1[/SUP], Cruz A[SUP]1[/SUP], P?rez-Patrigeon S[SUP]3[/SUP], Hidalgo A[SUP]4[/SUP], Orozco L[SUP]4[/SUP], Mart?nez A[SUP]4[/SUP], Padilla L[SUP]5[/SUP], Avila-Moreno F[SUP]6[/SUP], Cabello C[SUP]1[/SUP], Granados J[SUP]7[/SUP], Ortiz-Quintero B[SUP]1[/SUP], Ram?rez-Venegas A[SUP]1[/SUP], Ruiz-Palacios GM[SUP]3[/SUP], Zlotnik A[SUP]8[/SUP], Merino E[SUP]9[/SUP], Z??iga J[SUP]10[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Overproduction of pro-inflammatory cytokines and chemokines is frequently associated with severe clinical manifestations in A/H1N1. Micro-RNAs (miRNAs) are highly conserved small non-coding RNA molecules that post-transcriptionally regulate gene expression and are potential biomarkers and therapeutic targets in different inflammatory conditions METHODS: We studied the circulating and miRNA profiles in critically ill A/H1N1 patients, A/H1N1 patients with milder disease, asymptomatic housemates and healthy controls. Cytokine, chemokine and growth factors that were potential targets of differentially expressed miRNAs were assessed. Kyoto Encyclopedia of Genes and Genomes (KEEG) pathways enrichment and interactome analysis of these miRNAs were also performed RESULTS: Critically ill patients exhibited a significant over-expression of circulating miR-150 (p<0.005) when compared to patients with milder disease. miR-29c and miR-145 and miR-22 are differentially expressed in patients with severe A/H1N1 disease whereas miR-210, miR-126 and miR-222 are downregulated in individuals exposed to the A/H1N1 virus. Significant correlations (p<0.05) between circulating levels of miR-150 with IL-1ra, IL-2, IL-6, CXCL8, IFN-γ, CXCL10 and G-CSF were detected, particularly in critically ill patients CONCLUSION: The up-regulation of miR-150 is associated with poorer outcomes of A/H1N1 infection. The differential expression of miRNAs related with immune processes in severe A/H1N1 disease support the potential role of these miRNAs as biomarkers of disease progression.
Copyright ? 2015. Published by Elsevier Inc.


[h=4]KEYWORDS:[/h] Influenza; circulating microRNAs; critically ill patients; miR-150; miRNAs; pandemic influenza A/H1N1

PMID: 26148929 [PubMed - as supplied by publisher]
 
Back
Top Bottom